Which Rx-to-OTC Switches Could Be on the Horizon?

Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.

Mary M. Bridgeman, PharmD, BCPS, CGP, FASCP, clinical associate professor at the Ernesto Mario School of Pharmacy, Rutgers University, discusses potential Rx-to-OTC switches.

Related Content:

InterviewsRetail
Treatments for Thyroid Disease Are Generally Effective and Safe
US State Prescribing Laws May Limit Access to HIV Pre-Exposure Prophylaxis
FDA Grants Emergency Use Authorization to CRISPR High Throughput COVID-19 Test